Mrs Traci Johnson, | |
5607 W 75th Ter, Prairie Village, KS 66208-4517 | |
(913) 957-0623 | |
Not Available |
Full Name | Mrs Traci Johnson |
---|---|
Gender | Female |
Speciality | Social Worker |
Location | 5607 W 75th Ter, Prairie Village, Kansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457991358 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YS0200X | Counselor - School | 9167156576 (Kansas) | Secondary |
104100000X | Social Worker | 7918 (Kansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Traci Johnson, 5607 W 75th Ter, Prairie Village, KS 66208-4517 Ph: (913) 957-0623 | Mrs Traci Johnson, 5607 W 75th Ter, Prairie Village, KS 66208-4517 Ph: (913) 957-0623 |
News Archive
LifePoint Hospitals, Inc. today announced results for the second quarter and six months ended June 30, 2010.
Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, according to a new study published September 9 in the Journal of the National Cancer Institute.
A new method to reveal the structure of proteins could help researchers understand biological molecules - both those involved in causing disease and those performing critical functions in healthy cells.
A revolutionary nebuliser developed by RMIT University researchers could one day deliver life-saving cancer drugs and vaccines traditionally given by injection.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML).
› Verified 7 days ago